GreenLight Biosciences Holdings

Informe acción NasdaqGM:GRNA

Capitalización de mercado: US$45.4m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Dividendos de GreenLight Biosciences Holdings

Dividendo controles de criterios 0/6

GreenLight Biosciences Holdings does not have a record of paying a dividend.

Información clave

n/a

Rentabilidad por dividendo

n/a

Ratio de pago

Rentabilidad media de la industria2.8%
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acciónn/a
Beneficios por acción-US$1.04
Rentabilidad por dividendo prevista a 3 años0%

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

GreenLight Biosciences cutting 25% of staff as part of realignment

Oct 12

GreenLight Biosciences launches $109M in financing

Aug 12

GreenLight Biosciences, Samsung Biologics complete commercial-scale engineering run for mRNA COVID-19 vaccine

Aug 01

GreenLight Biosciences: Synthesizing Cell-Free RNA

Apr 05

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Insufficient data to determine if GRNA's dividends per share have been stable in the past.

Dividendo creciente: Insufficient data to determine if GRNA's dividend payments have been increasing.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de GreenLight Biosciences Holdings vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de GRNA con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (GRNA)n/a
Suelo de mercado 25% (US)1.5%
Techo de mercado 25% (US)4.6%
Media de la industria (Biotechs)2.8%
Previsión de analistas en 3 años (GRNA)0%

Dividendo destacado: Unable to evaluate GRNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Alto dividendo: Unable to evaluate GRNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Pago de beneficios a los accionistas

Cobertura de los beneficios: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Unable to calculate sustainability of dividends as GRNA has not reported any payouts.


Discover strong dividend paying companies